The MCG Patent Portfolio
To give you an idea of the type of inventions we have under
development, see the list given below. A
non-confidential summary and additional information will be provided for any of
these technologies upon request. You
may also access this information online in "Technologies
Available for License". Note that our list grows faster than we can even update the website, so
the best approach is to call or write with your specific needs or areas of
interest.
- Method
of detecting and grading dysplasia in epithelial tissue
- A
method for light-curing resin adhesives for orthodontics brackets
- Small
RNAs that bind to Ku protein and inhibit DNA-PK activity
- Regulation
of T-cell-medicated immunity by tryptophan
- High
affinity tryptophan transporters
- Method
of reducing dentin sensitivity and compositions thereof
- A
fluoride-releasing dental amalgam restoration material
- A
fluorescent agent for the identification of tooth dentin
- D-1
like dopamine receptor activity modifying protein
- Screen
for risk of gastric carcinoma
- Glucose-dependent
insulinotropic peptide as an osteoporic hormone
- Long
terminal repeat enhancer & insulator sequences for recombinant vectors
- Pyridinium
compounds
- Effect
of Rho kinase inhibitors on the erectile response
- Educational
modules on research clinical trials compliance
Revised
May 5, 2009.
Please send comments, suggestions or questions about this page to Charles Nawrot, Ph.D., Associate Vice President,
cnawrot@mcg.edu
.